Beligas Human Growth Hormones – 100IU

AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.

Copper peptide GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine with a strong affinity for copper(II).  It can also be found in human plasma, saliva, and urine. GHK-Cu is believed to work by binding to copper ions and activating various biological pathways, including the promotion of antioxidant activity, modulation of the immune response, and stimulation of cell proliferation and differentiation. There is good evidence that GHK-Cu is beneficial in wound healing, suppressing free-radical damage, increasing protein synthesis, fighting bacteria, and increasing the health of skin and fibroblasts. It has been found to stimulate collagen production, enhance wound healing, reduce scar formation, and improve skin elasticity. It has also been shown to have a positive effect on hair growth, bone density, and nerve regeneration.

Retatrutide is a Triple–Hormone-Receptor Agonist. Retatrutide is an investigational single molecule that activates the body’s receptors for three hormones – glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), and is being studied for the treatment of obesity. Retatrutide is an acylated peptide suitable for weekly injection.